These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30540467)

  • 1. Using Membrane Partitioning Simulations To Predict Permeability of Forty-Nine Drug-Like Molecules.
    Dickson CJ; Hornak V; Bednarczyk D; Duca JS
    J Chem Inf Model; 2019 Jan; 59(1):236-244. PubMed ID: 30540467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Kinetic Relationships of Passive Membrane Permeation from Multiscale Modeling.
    Dickson CJ; Hornak V; Pearlstein RA; Duca JS
    J Am Chem Soc; 2017 Jan; 139(1):442-452. PubMed ID: 27951634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Passive Permeability and Molecular Polarity Using Block Relevance Analysis.
    Goetz GH; Shalaeva M; Caron G; Ermondi G; Philippe L
    Mol Pharm; 2017 Feb; 14(2):386-393. PubMed ID: 28035823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDCKpred: a web-tool to calculate MDCK permeability coefficient of small molecule using membrane-interaction chemical features.
    Patel RD; Prasanth Kumar S; Pandya HA; Solanki HA
    Toxicol Mech Methods; 2018 Nov; 28(9):685-698. PubMed ID: 29998769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Passive Permeability of Drug-like Molecules from Chemical Structure: Where Are We?
    Broccatelli F; Salphati L; Plise E; Cheong J; Gobbi A; Lee ML; Aliagas I
    Mol Pharm; 2016 Dec; 13(12):4199-4208. PubMed ID: 27806577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 3D properties to characterize beyond rule-of-5 property space for passive permeation.
    Guimarães CR; Mathiowetz AM; Shalaeva M; Goetz G; Liras S
    J Chem Inf Model; 2012 Apr; 52(4):882-90. PubMed ID: 22394163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability.
    Winiwarter S; Ax F; Lennernäs H; Hallberg A; Pettersson C; Karlén A
    J Mol Graph Model; 2003 Jan; 21(4):273-87. PubMed ID: 12479927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional group dependence of solute partitioning to various locations within a DOPC bilayer: a comparison of molecular dynamics simulations with experiment.
    Tejwani RW; Davis ME; Anderson BD; Stouch TR
    J Pharm Sci; 2011 Jun; 100(6):2136-46. PubMed ID: 21491439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico screening of drug-membrane thermodynamics reveals linear relations between bulk partitioning and the potential of mean force.
    Menichetti R; Kanekal KH; Kremer K; Bereau T
    J Chem Phys; 2017 Sep; 147(12):125101. PubMed ID: 28964031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple Predictive Models of Passive Membrane Permeability Incorporating Size-Dependent Membrane-Water Partition.
    Leung SS; Sindhikara D; Jacobson MP
    J Chem Inf Model; 2016 May; 56(5):924-9. PubMed ID: 27135806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting MDCK cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.
    Chen LL; Yao J; Yang JB; Yang J
    Acta Pharmacol Sin; 2005 Nov; 26(11):1322-33. PubMed ID: 16225754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics trajectories for 630 coarse-grained drug-membrane permeations.
    Hoffmann C; Centi A; Menichetti R; Bereau T
    Sci Data; 2020 Feb; 7(1):51. PubMed ID: 32054852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.
    Shityakov S; Neuhaus W; Dandekar T; Förster C
    Int J Comput Biol Drug Des; 2013; 6(1-2):146-56. PubMed ID: 23428480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can membrane permeability of zwitterionic compounds be predicted by the solubility-diffusion model?
    Ebert A; Dahley C
    Eur J Pharm Sci; 2024 Aug; 199():106819. PubMed ID: 38815700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Back to the future: can physical models of passive membrane permeability help reduce drug candidate attrition and move us beyond QSPR?
    Swift RV; Amaro RE
    Chem Biol Drug Des; 2013 Jan; 81(1):61-71. PubMed ID: 23066853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar molecular descriptors determine the in vitro drug permeability in endothelial and epithelial cells.
    Hakkarainen JJ; Pajander J; Laitinen R; Suhonen M; Forsberg MM
    Int J Pharm; 2012 Oct; 436(1-2):426-43. PubMed ID: 22750947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of immobilized artificial membrane chromatography to predict human oral absorption.
    Tsopelas F; Vallianatou T; Tsantili-Kakoulidou A
    Eur J Pharm Sci; 2016 Jan; 81():82-93. PubMed ID: 26485055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of membrane defects-lessons from simulations.
    Bennett WF; Tieleman DP
    Acc Chem Res; 2014 Aug; 47(8):2244-51. PubMed ID: 24892900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between water permeation and flip-flop motion in a bilayer membrane.
    Inokuchi T; Arai N
    Phys Chem Chem Phys; 2018 Nov; 20(44):28155-28161. PubMed ID: 30387788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.